Tuberculosis treatment loss to follow-up in children exposed at home: A prospective cohort study

Meredith B Brooks1,2, Brittney J van de Water3, Leonid Lecca2,4

  • 1Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Journal of Global Health
|August 16, 2024
PubMed

Insights

More than 10% of children with tuberculosis (TB) treatment were lost to follow-up (LTFU). Family-centered care may improve treatment completion for pediatric TB cases.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Loss to follow-up (LTFU) is a major challenge in tuberculosis (TB) treatment and care.
  • Understanding drivers of LTFU in children is crucial, as their treatment relies on adult caregivers.
  • This study focuses on identifying risk factors for LTFU in pediatric TB patients within a household contact setting.

Purpose of the Study:

  • To identify risk factors associated with loss to follow-up (LTFU) among children undergoing tuberculosis (TB) treatment.
  • To inform the development of targeted support services for families affected by pediatric TB.

Main Methods:

  • A prospective cohort study was conducted with household contacts in Lima, Peru, from 2009 to 2012.
  • Multilevel logistic regression analysis was used to explore individual-level characteristics.
  • Risk factors for LTFU were identified among children initiated on TB treatment.

Main Results:

  • Out of 154 children diagnosed with TB and initiated on treatment, 20 (13.0%) were LTFU.
  • A significant proportion of LTFU occurred within the first seven months of treatment initiation.
  • Children with index patients older than 25 years had lower odds of LTFU compared to those with younger index patients.

Conclusions:

  • Over 10% of children with TB in this cohort experienced LTFU.
  • An integrated, family-centered approach to TB prevention and management could potentially reduce LTFU.
  • Addressing family-centered needs may improve treatment adherence and completion in pediatric TB cases.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
316